These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2498922)

  • 21. Protection by U-50,488H against beta-chlornaltrexamine antagonism of nitrous oxide antinociception in mice.
    Quock RM; Mueller J
    Brain Res; 1991 May; 549(1):162-4. PubMed ID: 1832578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice.
    Kiianmaa K; Hoffman PL; Tabakoff B
    Psychopharmacology (Berl); 1983; 79(4):291-4. PubMed ID: 6407041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defeat, learned submissiveness, and analgesia in mice: effect of genotype.
    Siegfried B; Frischknecht HR; Waser PG
    Behav Neural Biol; 1984 Sep; 42(1):91-7. PubMed ID: 6542355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
    Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
    Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D; Raehal KM; Bilsky EJ; Sadée W
    J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for delta-receptor involvement in the post-ictal antinociceptive responses to electroconvulsive shock in rats.
    Belenky GL; Gelinas-Sorell D; Kenner JR; Holaday JW
    Life Sci; 1983; 33 Suppl 1():583-5. PubMed ID: 6319914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic antagonist infusion does not increase morphine antinociception in rat spinal cord.
    Stevens CW; Yaksh TL
    Brain Res; 1987 Nov; 425(2):388-90. PubMed ID: 3427441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differences in the effects of naltrexone on the communicative and aggressive behaviors of subjects with different experiences of social conquests].
    Lipina TV; Avgustinovich DF; Koriakina LA; Aleksaeenko OV; Kudriavtseva NN
    Eksp Klin Farmakol; 1998; 61(3):13-8. PubMed ID: 9690068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Crain SM; Shen KF
    Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice.
    Nieder GL; Corder CN
    J Reprod Fertil; 1982 Jul; 65(2):341-6. PubMed ID: 7097642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FMRFamide, a putative endogenous opiate antagonist: evidence from suppression of defeat-induced analgesia and feeding in mice.
    Kavaliers M; Hirst M
    Neuropeptides; 1985 Dec; 6(6):485-94. PubMed ID: 4080110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supersensitivity to the behavioral effects of opiate antagonists [proceedings].
    Spealman RD; Kelleher RT; Morse WH; Goldberg SR
    Psychopharmacol Bull; 1981 Jan; 17(1):54-6. PubMed ID: 7232659
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of apomorphine-induced climbing in mice by reversible and irreversible narcotic antagonist drugs.
    Quock RM; Lucas TS
    Life Sci; 1981 Mar; 28(12):1421-4. PubMed ID: 7242242
    [No Abstract]   [Full Text] [Related]  

  • 35. "Paradoxical" analgesia induced by naloxone and naltrexone.
    Greeley JD; Lê AD; Poulos CX; Cappell H
    Psychopharmacology (Berl); 1988; 96(1):36-9. PubMed ID: 3147475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
    Larson AA; Armstrong MJ
    Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of opiate antagonists on social and aggressive behavior of isolated mice.
    Puglisi-Allegra S; Oliverio A; Mandel P
    Pharmacol Biochem Behav; 1982 Oct; 17(4):691-4. PubMed ID: 6891063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social conflict-induced changes in nociception and beta-endorphin-like immunoreactivity in pituitary and discrete brain areas of C57BL/6 and DBA/2 mice.
    Külling P; Frischknecht HR; Pasi A; Waser PG; Siegfried B
    Brain Res; 1988 May; 450(1-2):237-46. PubMed ID: 3401713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variance contributes to naltrexone-induced inhibition of sucrose intake in inbred and outbred mouse strains.
    Dym CT; Pinhas A; Ginzberg M; Kest B; Bodnar RJ
    Brain Res; 2007 Mar; 1135(1):136-45. PubMed ID: 17204254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of opiate agonists and antagonists on aggressive encounters and subsequent opioid-induced analgesia, activity and feeding responses in male mice.
    Teskey GC; Kavaliers M
    Pharmacol Biochem Behav; 1988 Sep; 31(1):43-52. PubMed ID: 3252259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.